Skip to main content

Organon & Co.

OGN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001821825

No open-market purchases or sales by Organon & Co. insiders were filed in the last 90 days; 638 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.

Holders of 5% or more of OGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Organon & Co., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of OGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A11.90%30.7M shares–Apr 30, 20251 filingApr 30, 2025SEC
Pentwater Capital Management LP13G6.90%18.1M sharesNewAug 14, 20261 filingAug 14, 2026SEC
Vanguard Portfolio Management LLC13G/A5.77%15.2M shares−2.70 ppfrom 8.47%Apr 29, 20262 filingsJul 31, 2026SEC
Vanguard Capital Management LLC13G5.26%13.7M sharesNewApr 30, 20261 filingApr 30, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

19 Schedule 13D and 13G filings on Organon & Co., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on OGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20264:21 PM ETPentwater Capital Management LPand 1 other13G6.90%18.1M sharesNewJun 30, 2026SEC
Jul 31, 202611:22 AM ETVanguard Portfolio Management LLC13G/A5.77%15.2M shares−2.70 ppfrom 8.47%Jun 30, 2026SEC
Apr 30, 202611:59 AM ETVanguard Capital Management LLC13G5.26%13.7M sharesNewMar 31, 2026SEC
Apr 29, 20262:41 PM ETVanguard Portfolio Management LLC13G8.47%22.1M sharesNewMar 31, 2026SEC
Mar 27, 202611:04 AM ETVanguard Group Inc13G/A0.00%0 shares−13.82 ppfrom 13.82%Below 5%Mar 13, 2026SEC
Oct 30, 20253:48 PM ETVanguard Group Inc13G/A13.82%35.9M shares–Sep 30, 2025SEC
Apr 30, 202510:12 AM ETBlackRock, Inc.13G/A11.90%30.7M shares–Mar 31, 2025SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Feb 5, 2024Mawer Investment Management Ltd.13G/AOld format–––SEC
Jan 25, 2024State Street Corp13G/AOld format–––SEC
Jan 23, 20244:13 PM ETBlackRock Inc.13G/AOld format–––SEC
Nov 7, 20233:33 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 13, 2023Mawer Investment Management Ltd.13GOld format–New–SEC
Feb 10, 2023State Street Corp13GOld format–New–SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 7, 20232:10 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–New–SEC
Jul 12, 2021Vanguard Group Inc13GOld format–New–SEC

Form 144: proposed insider sales

2 notices from officers, directors and other affiliates planning to sell Organon & Co. shares, newest first.

Form 144 notices for OGN
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Aug 5, 20264:26 PM ETJuliana P DrinaneOfficer14.8K$200.3KAug 5, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 8, 20268:31 PM ETHolzbaur LynetteAffiliate26.4K$353.1KMay 6, 2026Morgan Stanley Global Stock Plan ServicesSEC